Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Maher, E. R.
Right arrow Articles by Lees, A. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maher, E. R.
Right arrow Articles by Lees, A. J.
NEUROLOGY 1986;36:1005
© 1986 American Academy of Neurology

The clinical features and natural history of the Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy)

E. R. Maher, BSc, MRCP and A. J. Lees, MD, MRCP

National Hospitals for Nervous Diseases, Queen Square and Maida Vale, and the University College Hospital, London, England.

We analyzed the clinical features and natural history of 52 consecutive patients with the Steele-Richardson-Olszewski syndrome. The most common symptoms at onset were unsteady gait, backward falls because of poor balance, visual disturbances, slurred speech, and forgetfulness. The median duration from onset to death was 5.9 years, with a median survival after diagnosis of only 1.8 years. Bronchopneumonia was the usual cause of death recorded on death certificates.

Address correspondence and reprint requests to Dr. Lees, The National Hospitals for Nervous Diseases, Queen Square, London WC1N 3BG, England.

Accepted for publication November 13, 1985.




This article has been cited by other articles:


Home page
J. Neurol. Neurosurg. PsychiatryHome page
J-S Vidal, M Vidailhet, P Derkinderen, T D. de Gaillarbois, C Tzourio, and A Alperovitch
Risk factors for progressive supranuclear palsy: a case-control study in France
J. Neurol. Neurosurg. Psychiatry, November 1, 2009; 80(11): 1271 - 1274.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
A. Erbetta, M.L. Mandelli, M. Savoiardo, M. Grisoli, A. Bizzi, P. Soliveri, L. Chiapparini, S. Prioni, M.G. Bruzzone, and F. Girotti
Diffusion Tensor Imaging Shows Different Topographic Involvement of the Thalamus in Progressive Supranuclear Palsy and Corticobasal Degeneration
AJNR Am. J. Neuroradiol., September 1, 2009; 30(8): 1482 - 1487.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
L. B. Oude Nijhuis, J. H. J. Allum, G. F. Borm, F. Honegger, S. Overeem, and B. R. Bloem
Directional Sensitivity of "First Trial" Reactions in Human Balance Control
J Neurophysiol, June 1, 2009; 101(6): 2802 - 2814.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
S. S. O'Sullivan, L. A. Massey, D. R. Williams, L. Silveira-Moriyama, P. A. Kempster, J. L. Holton, T. Revesz, and A. J. Lees
Clinical outcomes of progressive supranuclear palsy and multiple system atrophy
Brain, May 1, 2008; 131(5): 1362 - 1372.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
N M Warren, M A Piggott, A J Lees, and D J Burn
The basal ganglia cholinergic neurochemistry of progressive supranuclear palsy and other neurodegenerative diseases
J. Neurol. Neurosurg. Psychiatry, June 1, 2007; 78(6): 571 - 575.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
L. I. Golbe and P. A. Ohman-Strickland
A clinical rating scale for progressive supranuclear palsy
Brain, June 1, 2007; 130(6): 1552 - 1565.
[Abstract] [Full Text] [PDF]


Home page
PNHome page
N. M Warren and D. J Burn
Progressive supranuclear palsy
Practical Neurology, February 1, 2007; 7(1): 16 - 23.
[Full Text] [PDF]


Home page
NeurologyHome page
A. Schrag, C. Selai, N. Quinn, A. Lees, I. Litvan, A. Lang, Y. Poon, J. Bower, D. Burn, and J. Hobart
Measuring quality of life in PSP: The PSP-QoL.
Neurology, July 11, 2006; 67(1): 39 - 44.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
A M Pittman, A J Myers, P Abou-Sleiman, H C Fung, M Kaleem, L Marlowe, J Duckworth, D Leung, D Williams, L Kilford, et al.
Linkage disequilibrium fine mapping and haplotype association analysis of the tau gene in progressive supranuclear palsy and corticobasal degeneration
J. Med. Genet., November 1, 2005; 42(11): 837 - 846.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
D. R. Williams, R. de Silva, D. C. Paviour, A. Pittman, H. C. Watt, L. Kilford, J. L. Holton, T. Revesz, and A. J. Lees
Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism
Brain, June 1, 2005; 128(6): 1247 - 1258.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
U Nath, R Thomson, R Wood, Y Ben-Shlomo, A Lees, C Rooney, and D Burn
Population based mortality and quality of death certification in progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome)
J. Neurol. Neurosurg. Psychiatry, April 1, 2005; 76(4): 498 - 502.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
S. Papapetropoulos, T. Scaravilli, H. Morris, S. F. An, D. C. Henderson, N. P. Quinn, F. Scaravilli, and K. P. Bhatia
Young onset limb spasticity with PSP-like brain and spinal cord NFT-tau pathology
Neurology, February 22, 2005; 64(4): 731 - 733.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
P. Soliveri, S. Piacentini, and F. Girotti
Limb apraxia in corticobasal degeneration and progressive supranuclear palsy
Neurology, February 8, 2005; 64(3): 448 - 453.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
H.R. Morris, Y. Osaki, J. Holton, A.J. Lees, N.W. Wood, T. Revesz, and N. Quinn
Tau exon 10 +16 mutation FTDP-17 presenting clinically as sporadic young onset PSP
Neurology, July 8, 2003; 61(1): 102 - 104.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
U. Nath, Y. Ben-Shlomo, R.G. Thomson, A.J. Lees, and D.J. Burn
Clinical features and natural history of progressive supranuclear palsy: A clinical cohort study
Neurology, March 25, 2003; 60(6): 910 - 916.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
C. G. Goetz, S. Leurgans, A. E. Lang, and I. Litvan
Progression of gait, speech and swallowing deficits in progressive supranuclear palsy
Neurology, March 25, 2003; 60(6): 917 - 922.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
M. Suzuki, T. J. Desmond, R. L. Albin, and K. A. Frey
Cholinergic vesicular transporters in progressive supranuclear palsy
Neurology, April 9, 2002; 58(7): 1013 - 1018.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
D. J Brooks
DIAGNOSIS AND MANAGEMENT OF ATYPICAL PARKINSONIAN SYNDROMES
J. Neurol. Neurosurg. Psychiatry, March 1, 2002; 72(90001): i10 - 16.
[Full Text] [PDF]


Home page
BrainHome page
U. Nath, Y. Ben-Shlomo, R. G. Thomson, H. R. Morris, N. W. Wood, A. J. Lees, and D. J. Burn
The prevalence of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) in the UK
Brain, July 1, 2001; 124(7): 1438 - 1449.
[Abstract] [Full Text] [PDF]


Home page
J Geriatr Psychiatry NeurolHome page
M. S. Nobler, G. H. Pelton, and H. A. Sackeim
Cerebral Blood Flow and Metabolism in Late-Life Depression and Dementia
J Geriatr Psychiatry Neurol, October 1, 1999; 12(3): 118 - 127.
[Abstract] [PDF]


Home page
Arch NeurolHome page
J. Ghika and J. Bogousslavsky
Presymptomatic Hypertension Is a Major Feature in the Diagnosis of Progressive Supranuclear Palsy
Arch Neurol, September 1, 1997; 54(9): 1104 - 1108.
[Abstract] [PDF]


Home page
NEJMHome page
R. G. Feldman and A. C. McKee
Case 46-1993- A 75-Year-Old Man with Right-Sided Rigidity, Dysarthria, and Abnormal Gait
N. Engl. J. Med., November 18, 1993; 329(21): 1560 - 1567.
[Full Text]


Home page
Arch NeurolHome page
M. Kobari, Y. Fukuuchi, T. Shinohara, S. Nogawa, and K. Takahashi
Local Cerebral Blood Flow and Its Response to Intravenous Levodopa in Progressive Supranuclear Palsy: Comparison With Parkinson's Disease
Arch Neurol, July 1, 1992; 49(7): 725 - 730.
[Abstract] [PDF]


Home page
Arch NeurolHome page
M. H. Bhatt, B. J. Snow, W. R. W. Martin, R. Peppard, and D. B. Calne
Positron Emission Tomography in Progressive Supranuclear Palsy
Arch Neurol, April 1, 1991; 48(4): 389 - 391.
[Abstract] [PDF]


Home page
Arch NeurolHome page
J. Blin, J. C. Baron, B. Dubois, B. Pillon, H. Cambon, J. Cambier, and Y. Agid
Positron Emission Tomography Study in Progressive Supranuclear Palsy: Brain Hypometabolic Pattern and Clinicometabolic Correlations
Arch Neurol, July 1, 1990; 47(7): 747 - 752.
[Abstract] [PDF]


Home page
Arch NeurolHome page
J. Grafman, I. Litvan, C. Gomez, and T. N. Chase
Frontal Lobe Function in Progressive Supranuclear Palsy
Arch Neurol, May 1, 1990; 47(5): 553 - 558.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1986 by AAN Enterprises, Inc.